For the Inventor, By the Inventor

Enter assignee name

R-Tech Ueno, Ltd.

USPTO Granted Patents = 55

CIPO Patents = 1

EPO Patents = 14

Forward Citations = 342

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Ryuji Ueno (41 out of 151 patents)

Ryu Hirata (12 out of 13 patents)

Tatsuya Matsukawa (11 out of 12 patents)

4. Kazuhiro Masuzaki (7 out of 7 patents)

5. Yasuhiro Harada (7 out of 8 patents)

6. Ryuzo Ueno (6 out of 108 patents)

7. Tomio Oda (6 out of 32 patents)

8. Ichie Kato (4 out of 14 patents)

9. Akiko Kawasaki (3 out of 3 patents)

10. Akiko Akasaka (3 out of 3 patents)

11. Yosuke Kawai (3 out of 3 patents)

12. Yukiko Hashitera (3 out of 3 patents)

13. Yukihiko Mashima (3 out of 4 patents)

14. Junichi Kawasaki (2 out of 2 patents)

15. Yoshie Nishimura (2 out of 2 patents)

Core Competencies:

VAP-1 Inhibitor

Prostaglandin Derivative

Ophthalmic Composition

Soft-Gelatin Capsule

Hair Growth Promotion

Ocular Hypertension Treatment

Endothelin Antagonist

Pharmaceutical Composition

Fatty Acid Derivative

Optic Nerve Disorder Treatment

Wound Healing Promotion

Benzene Derivative

55 patents: Sort by Forward Citations

1. 9603833 - Benzene or thiophene derivative and use thereof as VAP-1 inhibitor (2017-03-28),

2. 9254326 - Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound (2016-02-09),

3. 9254306 - Eye drops (2016-02-09),

4. 9242950 - Method for preparing a fatty acid derivative (2016-01-26),

5. 9212158 - Method for preparing a fatty acid derivative (2015-12-15),

6. 9205154 - Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method (2015-12-08),

7. 8999989 - Benzene or thiophene derivative and use thereof as VAP-1 inhibitor (2015-04-07),

8. 8969324 - Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound (2015-03-03),

9. 8871995 - Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and pharmaceutical composition obtained by the method (2014-10-28),

10. 8779187 - Soft-gelatin capsule formulation (2014-07-15),

11. 8686035 - Composition and method for promoting hair growth (2014-04-01),

12. 8669284 - Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound (2014-03-11),

13. 8507690 - Thiazole derivative and use thereof as VAP-1 inhibitor (2013-08-13),

14. 8389748 - Method for preparing prostaglandin derivative (2013-03-05),

15. 8338639 - Soft-gelatin capsule formulation (2012-12-25),

R-Tech Ueno, Ltd. is a pharmaceutical company focused on the research and development of innovative drugs. With a strong emphasis on ophthalmology, R-Tech Ueno is dedicated to improving the lives of patients worldwide through the discovery and commercialization of novel therapies. Through continuous innovation and collaboration, R-Tech Ueno strives to contribute to the advancement of medical science and promote better healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

55 Patents

#667 in Tokyo

#1,582 in Japan

#12,578 in the World

R-Tech Ueno, Ltd.

Forward Citations = 342

42 inventors:

Ryuji Ueno (41 out of 151 patents)

Ryu Hirata (12 out of 13 patents)

Tatsuya Matsukawa (11 out of 12 patents)

4. Kazuhiro Masuzaki (7 out of 7 patents)

5. Yasuhiro Harada (7 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…